John Abbott's Stock Ratings

Wolfe Research Analyst

John Abbott is an analyst at Wolfe Research. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/19/2024

Overall Average Return

-0.50%

Smart Score

47.3%

Overall Average Return Percentile

34th

Number of Ratings

15
Buy NowGet Alert
07/18/2024CRGYBuy Now
Crescent Energy
$12.14Reinstates → OutperformGet Alert
03/08/2024ARCTBuy Now
Arcturus Therapeutics
$23.42147.65%$45 → $58MaintainsOverweightGet Alert
01/05/2024NOGBuy Now
Northern Oil & Gas
$41.65-6.36% → $39DowngradeBuy → UnderperformGet Alert
12/08/2023VTLEBuy Now
Vital Energy
$45.964.44% → $48Initiates → UnderperformGet Alert
11/07/2023GRNTBuy Now
Granite Ridge Resources
$6.9529.5% → $9Initiates → BuyGet Alert
01/25/2023CRGYBuy Now
Crescent Energy
$12.1415.32%$13 → $14DowngradeNeutral → UnderperformGet Alert
01/25/2023CHRDBuy Now
Chord Energy
$175.341.52% → $178Initiates → BuyGet Alert
11/15/2022CRGYBuy Now
Crescent Energy
$12.1423.56% → $15Initiates → NeutralGet Alert
08/10/2022ARCTBuy Now
Arcturus Therapeutics
$23.42318.45%$105 → $98MaintainsOverweightGet Alert
07/19/2022NOGBuy Now
Northern Oil & Gas
$41.65-23.17%$38 → $32MaintainsNeutralGet Alert
03/25/2022ARCTBuy Now
Arcturus Therapeutics
$23.42348.33%$107 → $105MaintainsOverweightGet Alert
03/08/2022NOGBuy Now
Northern Oil & Gas
$41.65DowngradeBuy → NeutralGet Alert
03/01/2022ARCTBuy Now
Arcturus Therapeutics
$23.42356.87%$118 → $107MaintainsOverweightGet Alert
01/11/2022CYADBuy Now
Celyad Oncology
$20 → $11MaintainsOverweightGet Alert
12/17/2021NOGBuy Now
Northern Oil & Gas
$41.65-32.77%UpgradeNeutral → BuyGet Alert